Key Insights

Highlights

Treatment Research

3 treatments under study, led by Substudy Only Maternalinfant Pharmacogenomic Assessment Postnatally

Research Leaders

9 sponsors active, led by Medical College of Wisconsin

Related Conditions

Often studied with 20 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 5 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown3
Not Yet Recruiting1
Recruiting1

Clinical Trials (5)

Research Network

Common Treatments

  • Substudy Only Maternalinfant Pharmacogenomic Assessment Postnatally1
  • Determination Of Causes Of Fetal Death1
  • Fetal Magnetocardiogram And Neonatal Electrocardiogram1

Active Sponsors

  • Medical College of Wisconsin1
  • Advancing a Healthier Wisconsin Endowment1
  • University of Wisconsin, Madison1
  • National Heart, Lung, and Blood Institute (NHLBI)1
  • Tel-Aviv Sourasky Medical Center1

Top Investigators

Related Conditions

  • Fetal Tachycardia1
  • Brugada Syndrome1
  • Preeclampsia1
  • Pregnancy Complications1
  • Fetal Arrhythmia1

Activity Timeline